Group 1 - Jebang Technology (301326.SZ) reported its Q3 2025 results, with 18 institutional investors holding a total of 55.9761 million shares, representing 76.99% of the total share capital [1] - The top ten institutional investors collectively hold 75.24% of the shares, a decrease of 2.08 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, one fund, Penghua Consumer Select Mixed Fund, increased its holdings by 0.23% compared to the previous period [2] - One public fund, Penghua Core Advantage Mixed A, saw a slight decrease in holdings [2] - Nine new public funds were disclosed this period, including various funds from the Fortune series [2] - One insurance fund, Qianhai Life Insurance Co., Ltd. - Dividend Insurance Product, reported a slight decrease in holdings [2] - Two pension funds were not disclosed this quarter, both related to Qianhai Life Insurance [2]

Core Viewpoint - Weiteng Electric (688226.SH) reported a decrease in institutional ownership in its third-quarter report for 2025, with a total of 8 institutional investors holding 69.23 million shares, representing 36.89% of the total share capital, down by 1.71 percentage points from the previous quarter [1] Institutional Ownership - As of October 28, 2025, 8 institutional investors disclosed their holdings in Weiteng Electric, totaling 69.23 million shares, which is 36.89% of the company's total share capital [1] - The institutional ownership decreased by 1.71 percentage points compared to the previous quarter [1] Public Fund Holdings - One public fund, the Quan Guo Xu Yuan Three-Year Holding Period Mixed A, reported a decrease in holdings, with a reduction of 0.25% [1] - A total of 48 public funds did not disclose their holdings this quarter, including notable funds such as the Fortune Innovation Technology Mixed A and the E Fund Shanghai Stock Exchange Science and Technology Innovation Board Comprehensive ETF [1]

Core Viewpoint - Zhongyi Technology (301208.SZ) reported its Q3 2025 results, indicating a decline in institutional ownership and changes in public fund holdings [1] Institutional Ownership - As of October 23, 2025, there is one institutional investor holding shares in Zhongyi Technology, with a total of 882,900 shares, representing 0.74% of the total share capital [1] - The institutional ownership percentage decreased by 1.26 percentage points compared to the previous quarter [1] Public Fund Holdings - One public fund, the Huabao Zhongzheng Financial Technology Theme ETF, increased its holdings by 0.37% compared to the last period [1] - A total of 20 public funds that were previously disclosed have not reported their holdings this quarter, including notable funds such as Galaxy and Meisheng Mixed A, Bosera Financial Technology ETF, and others [1] Foreign Investment - The report indicates that BARCLAYS BANK PLC is the foreign institution that has not disclosed its holdings this quarter, compared to the previous quarter [1]

Core Insights - In August 2023, 96.34% of the 8742 comparable mixed funds reported a net value increase, with only 311 funds showing a decline [1] - A total of 25 mixed funds achieved a monthly increase of over 42%, with the top performers including Chang'an Xinrui Technology and Huatai-PB Quality Selection funds [1][2] - The Huatai-PB Quality Selection mixed funds have shown significant returns, with year-to-date returns of 107.78% and 107.09% respectively [1] - The fund manager for Huatai-PB Quality Selection is Chen Wenkai, who has a background in research and fund management [2] - The FuGuo Innovation Technology mixed fund also performed well, with a year-to-date return of 94.35% and a total return since inception of 137.30% [2] - In August, 20 mixed funds experienced a decline of over 3%, with the worst performers being from Dongwu Wisdom Medical and Oriental Alpha Health Industry [3] Fund Performance - The top five mixed funds in terms of monthly increase were: 1. Chang'an Xinrui Technology 6-Month Open Mixed A: 48.39% 2. Chang'an Xinrui Technology 6-Month Open Mixed C: 48.33% 3. Xin'ao Performance Driven Mixed A: 46.03% 4. Xin'ao Performance Driven Mixed C: 45.96% 5. Huatai-PB Quality Selection Mixed A: 43.40% [4] - The worst-performing funds in August included: 1. Dongwu Wisdom Medical Quantitative Mixed C: -4.29% 2. Dongwu Wisdom Medical Quantitative Mixed A: -4.25% 3. Oriental Alpha Health Industry Mixed Initiated C: -3.77% 4. Oriental Alpha Health Industry Mixed Initiated A: -3.73% [3] Fund Management - The current fund manager for Huatai-PB Quality Selection is Chen Wenkai, who has been with Huatai-PB since December 2019 [2] - The FuGuo Innovation Technology mixed fund is managed by Luo Qing, who joined FuGuo in January 2025 [3]

Core Viewpoint - The China Securities Regulatory Commission has introduced a performance-based compensation mechanism for fund managers, linking their pay to long-term performance against benchmarks [1] Group 1: Fund Performance and Management - Among funds with over 1 billion in size and established for more than three years, 356 funds have underperformed their benchmarks by over 10% in the last three years, involving 265 fund managers and 61 fund companies [2] - The "Fuguo Innovation Technology Mixed A" fund has a total scale of 2.253 billion yuan and has significantly underperformed its benchmark by 51.59%, with a three-year loss of 30.19% [2][4] - Fund manager Li Yuanbo has managed the fund for over 8 years, achieving a total return of 17.00% during his tenure, with a focus on technology sectors [4] Group 2: Investment Strategy and Risks - The fund has a high concentration in the technology sector, with 47% in semiconductors and about 20% in computer and communication sectors, reflecting a significant growth style [5] - The fund's maximum drawdown in the past year reached -28.52%, indicating high volatility and risk associated with its concentrated holdings [5] - The fund's asset management fees have been declining from 67.69 million yuan in 2022 to 34.77 million yuan in 2024 [6] Group 3: Market Outlook and Manager's Perspective - Li Yuanbo maintains a positive outlook on artificial intelligence and related sectors, despite the fund's recent performance challenges [10][11] - The fund's turnover rate was exceptionally high at 452% in 2024, indicating an active management strategy aimed at capturing market trends [10] - The manager expresses optimism about the fundamentals of the innovative drug sector and other industries showing improvement, such as engineering machinery and new energy [11]